Studycast Acquires UltraLinQ, Uniting Two Leaders in Cloud-Based Medical Imaging

RALEIGH, N.C., Aug. 26, 2025 /PRNewswire/ — Core Sound Imaging, the company behind the widely established Studycast® medical imaging workflow platform, today announced the acquisition of UltraLinQ Healthcare Solutions, a trusted provider of cloud-based PACS and cardiac monitoring solutions. This platform expansion is part of Studycast’s strategic growth initiative to consolidate strong imaging solutions under one robust platform.

The acquisition marks a significant milestone in the progression of cloud-based medical imaging, combining the strengths of two established platforms. Studycast, known for its scalable and intuitive imaging workflow, will now support an even broader base of healthcare providers, from small practices to large hospital networks.

“We’ve long admired UltraLinQ’s commitment to the same tenets as Core Sound Imaging: delivering some of the most advanced, dependable, and user-friendly imaging experience in the industry,” said Lindsey Klein, CEO of Core Sound Imaging. “This acquisition allows us to further solidify that promise to our customers and the market.”

UltraLinQ Chief Operations Officer Theo Vouniseas says that the acquisition marks an exciting opportunity for customers.

“UltraLinQ prioritizes simplicity, reliability, and customer support,” he said. “Joining forces with Studycast allows us to elevate that mission by offering our customers a more powerful platform without compromising on the values they trust.”

UltraLinQ customers will gain access to Studycast’s advanced features, including:

  • Seamless integration across EMRs and modalities
  • Access to AI-enhanced diagnostic tools
  • User-configurable worksheets and studies pages
  • Workflow automation tools to improve turnaround times
  • Over 120 study-specific worksheets and reports
  • Mobile-friendly interface
  • Superior training and support

“We’re committed to making this transition as smooth and beneficial as possible for our users,” Theo Vouniseas said.

In 2024, Core Sound Imaging announced an $80 million growth investment from PSG, a leading growth equity firm that focuses on partnering with software and technology-enabled services organizations to drive transformational growth.

About Core Sound Imaging

Since 2007, Core Sound Imaging has provided specialized solutions for the medical imaging workflow, including image storage, a zero-footprint viewer, and a suite of interpretation and structured reporting tools. The company’s flagship solution, the Studycast system, is currently used by hospitals, private practices, clinical research labs, and education programs in 49 US states and seven countries. For more information, visit corestudycast.com.

About UltraLinQ

UltraLinQ is a cloud-based PACS and cardiac monitoring platform serving more than 70,000 users across 8,000+ locations. Known for its intuitive interface and strong cardiology tools, UltraLinQ has been a trusted partner in diagnostic imaging for nearly two decades.

About PSG

PSG is a growth equity firm that partners with software and technology-enabled services companies to help them navigate transformational growth, capitalize on strategic opportunities, and build strong teams. Having backed more than 150 companies and facilitated over 520 add-on acquisitions, PSG brings extensive investment experience, deep expertise in software and technology, and a firm commitment to collaborating with management teams. Founded in 2014, PSG operates out of offices in Boston, Kansas City, London, Madrid, Paris, and Tel-Aviv. To learn more about PSG, visit psgequity.com.

Media Contact
PSG
Jackie Ryan
pro-psg@prosek.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/studycast-acquires-ultralinq-uniting-two-leaders-in-cloud-based-medical-imaging-302537848.html

SOURCE Core Sound Imaging, Inc.

Staff

Recent Posts

More Than a Meal Plan: The Clinical Impact of a Kidney Dietitian

NORTHAMPTON, MA / ACCESS Newswire / December 26, 2025 / Specialized nutrition experts are key…

52 minutes ago

President Trump’s Executive Marijuana Action Exposes the Truth-How the DEA Delayed Medicine While Protecting Everything Else

"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within…

52 minutes ago

From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream

WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…

4 hours ago

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

7 hours ago

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…

7 hours ago

Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources

DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…

7 hours ago